Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
- PMID: 31164428
- DOI: 10.1183/13993003.00531-2019
Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Abstract
Background: Mosaic attenuation on computed tomography (CT) has been identified in international guidelines as an important diagnostic feature of fibrotic hypersensitivity pneumonitis (FHP) as opposed to idiopathic pulmonary fibrosis (IPF). However, mosaic attenuation comprises several different radiological signs (low-density lobules, preserved lobules, air trapping and the so-called "headcheese sign") which may have differing diagnostic utility. Furthermore, the extent of mosaic attenuation required to distinguish these two diagnoses is uncertain and thresholds of mosaic attenuation from international guidelines have not been validated.
Methods: Inspiratory and expiratory CT scans were evaluated by two readers in 102 patients (IPF n=57; FHP n=45) using a semiquantitative scoring system for mosaic attenuation. Findings were validated in an external cohort from a secondary referral institution (IPF n=34; FHP n=28).
Results: Low-density lobules and air trapping were a frequent finding in IPF, present in up to 51% of patients. A requirement for increasing extent of low-density lobules and air trapping based on guidelines (American Thoracic Society and Fleischner Society) was associated with increased specificity for the diagnosis of FHP (0.96 and 0.98, respectively) but reduced sensitivity (0.16 and 0.20, respectively). The headcheese sign was found to be highly specific (0.93) and moderately sensitive (0.49) for a high-confidence diagnosis of FHP. The high specificity of the headcheese sign was maintained in the validation cohort and when patients with other CT features of FHP were excluded.
Conclusion: Mosaic attenuation is a frequent finding in IPF. However, the headcheese sign can be confidently considered as being inconsistent with a diagnosis of IPF and specific for FHP.
Copyright ©ERS 2019.
Conflict of interest statement
Conflict of interest: J. Barnett has nothing to disclose. Conflict of interest: P.L. Molyneaux has, via his institution, received industry academic funding from Roche, Boehringer Ingelheim and Galapagos, and has received lecture fees from Roche. Conflict of interest: B. Rawal has nothing to disclose. Conflict of interest: R. Abdullah has nothing to disclose. Conflict of interest: S.S. Hare has nothing to disclose. Conflict of interest: R. Vancheeswaran has nothing to disclose. Conflict of interest: S.R. Desai is co-organiser of an educational course convened by Boehringer Ingelheim. This is a “hands-on” workshop for pulmonologists and radiologists working in the field. The aim of the course is purely educational and does not focus on any particular disease (and specifically not IPF or hypersensitivity pneumonitis), nor does it promote any specific treatment or management. Conflict of interest: T.M. Maher has, via his institution, received industry academic funding from GlaxoSmithKline R&D and UCB, and has received consultancy or lecture fees from Apellis, AstraZeneca, aTyr Pharma, Bayer, Biogen Idec, Boehringer Ingelheim, Galapagos, GlaxoSmithKline R&D, Indalo, Pliant, ProMetic, Roche, Samumed and UCB, and has stock options in Apellis. Conflict of interest: A.U. Wells reports personal fees from Intermune, Boehringer Ingelheim, Gilead, MSD, Roche, Bayer and Chiesi, outside the submitted work. Conflict of interest: A. Devaraj reports personal fees from GlaxoSmithKline, Roche and Boehringer Ingelheim, outside the submitted work.
Comment in
-
Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of grey.Eur Respir J. 2019 Jul 25;54(1):1900906. doi: 10.1183/13993003.00906-2019. Print 2019 Jul. Eur Respir J. 2019. PMID: 31345989 No abstract available.
Similar articles
-
Chronic hypersensitivity pneumonitis or idiopathic pulmonary fibrosis? Diagnostic role of high resolution Computed Tomography (HRCT).Radiol Med. 2003 Sep;106(3):135-46. Radiol Med. 2003. PMID: 14612834 English, Italian.
-
[Comparative pathomorphological characteristics of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis].Arkh Patol. 2022;84(1):59-66. doi: 10.17116/patol20228401159. Arkh Patol. 2022. PMID: 35166480 Russian.
-
Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis.Respir Investig. 2024 Sep;62(5):798-803. doi: 10.1016/j.resinv.2024.07.002. Epub 2024 Jul 11. Respir Investig. 2024. PMID: 38996781
-
Pathologic Criteria for the Diagnosis of Usual Interstitial Pneumonia vs Fibrotic Hypersensitivity Pneumonitis in Transbronchial Cryobiopsies.Mod Pathol. 2023 Sep;36(9):100221. doi: 10.1016/j.modpat.2023.100221. Epub 2023 May 24. Mod Pathol. 2023. PMID: 37236510 Review.
-
Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.Chest. 2022 Sep;162(3):614-629. doi: 10.1016/j.chest.2022.06.013. Epub 2022 Jun 20. Chest. 2022. PMID: 35738345 Review.
Cited by
-
High-resolution computed tomography features of asbestosis versus fibrotic hypersensitivity pneumonitis: an observational study.BMC Pulm Med. 2022 May 25;22(1):207. doi: 10.1186/s12890-022-01967-3. BMC Pulm Med. 2022. PMID: 35614422 Free PMC article.
-
Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36-e69. doi: 10.1164/rccm.202005-2032ST. Am J Respir Crit Care Med. 2020. PMID: 32706311 Free PMC article.
-
A Low Forced Vital Capacity (FVC)/Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) Ratio Increases Clinical Suspicion for Fibrotic Hypersensitivity Pneumonitis (FHP) Over Idiopathic Pulmonary Fibrosis (IPF).Cureus. 2024 Nov 4;16(11):e73008. doi: 10.7759/cureus.73008. eCollection 2024 Nov. Cureus. 2024. PMID: 39634966 Free PMC article.
-
Current Diagnosis and Management of Hypersensitivity Pneumonitis.Tuberc Respir Dis (Seoul). 2020 Apr;83(2):122-131. doi: 10.4046/trd.2020.0012. Epub 2020 Mar 10. Tuberc Respir Dis (Seoul). 2020. PMID: 32185914 Free PMC article. Review.
-
Clinical diagnosis of patients subjected to surgical lung biopsy with a probable usual interstitial pneumonia pattern on high-resolution computed tomography.BMC Pulm Med. 2020 Nov 16;20(1):299. doi: 10.1186/s12890-020-01339-9. BMC Pulm Med. 2020. PMID: 33198708 Free PMC article.